Introduction Oral anticoagulants (OACs) prevent stroke in patients with atrial fibrillation (AF).
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …

Background Important disparities in the treatment and outcomes of women and men with
atrial fibrillation (AF) are well recognized. Whether introduction of direct oral anticoagulants …

Atrial fibrillation (AF) is the most prevalent arrhythmia in the United States and is responsible
for 1 in 7 ischemic strokes. While anticoagulation is effective at preventing strokes, prior work …

Advance Access Publication Date: 16 January 2020 Data Resource Profile geographically
organized into Primary Healthcare Districts (around 5000–25 000 people served by one …

Introduction: The use of vitamin K antagonists (VKAs) in non-valvular atrial fibrillation (NVAF)
is complicated due to the narrow therapeutic margin they present and their unpredictable …

Abstract What is Known and Objective Anticoagulants are indicated for treatment and
prevention of several clinical conditions. Prior studies have examined anticoagulant …

Methods: The INR data were retrospectively obtained from all patients taking warfarin during
2014-2016 at a secondary healthcare system in rural Chhattisgarh, India. Patients attending …

Background and purpose Real-world data about treatment convenience and satisfaction in
Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K …

Atrial fibrillation (AF) is considered the most common sustained cardiac arrhythmia, and it is
associated with a significant risk of adverse events, especially ischemic stroke. Oral …

Introduction and objectives The aim of this analysis was to evaluate the burden and cost of
complications due to poor anticoagulation control in patients with nonvalvular atrial …